Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1991 Feb;44(2):139–143. doi: 10.1136/jcp.44.2.139

Distribution of plasminogen activator inhibitor (PAI-1) in tissues.

A J Simpson 1, N A Booth 1, N R Moore 1, B Bennett 1
PMCID: PMC496976  PMID: 1864986

Abstract

Extracts of human tissue were analysed for plasminogen activator inhibitor (PAI-1) antigen and activity. PAI-1 was localised in tissues by an immunochemical method, using monoclonal antibodies. PAI-1 occurred throughout the body; its concentration and activity differed considerably from organ to organ. Extracts of liver and spleen had the greatest abundance of PAI-1, but the activity of the inhibitor was much higher in liver than in spleen: the liver may be a source of plasma PAI-1. Immunochemical staining for PAI-1 was observed in endothelium, platelets and their precursor cells, the megakaryocytes, and locations central to the process of haemostasis. PAI-1 also occurred in neutrophil polymorphs and macrophages, cells important in inflammatory and immune processes, but not in lymphocytes. Other cell types, in particular, vascular smooth muscle cells and mesangial cells, also stained positively for PAI-1 and such cells seem to represent an important reservoir of PAI-1.

Full text

PDF
139

Images in this article

141Image
on p.141
141Image
on p.141
142Image
on p.142
142Image
on p.142

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Booth N. A., Anderson J. A., Bennett B. Platelet release protein which inhibits plasminogen activators. J Clin Pathol. 1985 Jul;38(7):825–830. doi: 10.1136/jcp.38.7.825. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Booth N. A., Simpson A. J., Croll A., Bennett B., MacGregor I. R. Plasminogen activator inhibitor (PAI-1) in plasma and platelets. Br J Haematol. 1988 Nov;70(3):327–333. doi: 10.1111/j.1365-2141.1988.tb02490.x. [DOI] [PubMed] [Google Scholar]
  3. Chmielewska J., Wiman B. Determination of tissue plasminogen activator and its "fast" inhibitor in plasma. Clin Chem. 1986 Mar;32(3):482–485. [PubMed] [Google Scholar]
  4. Cordell J. L., Falini B., Erber W. N., Ghosh A. K., Abdulaziz Z., MacDonald S., Pulford K. A., Stein H., Mason D. Y. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem. 1984 Feb;32(2):219–229. doi: 10.1177/32.2.6198355. [DOI] [PubMed] [Google Scholar]
  5. Erickson L. A., Ginsberg M. H., Loskutoff D. J. Detection and partial characterization of an inhibitor of plasminogen activator in human platelets. J Clin Invest. 1984 Oct;74(4):1465–1472. doi: 10.1172/JCI111559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Juhan-Vague I., Moerman B., De Cock F., Aillaud M. F., Collen D. Plasma levels of a specific inhibitor of tissue-type plasminogen activator (and urokinase) in normal and pathological conditions. Thromb Res. 1984 Mar 1;33(5):523–530. doi: 10.1016/0049-3848(84)90018-5. [DOI] [PubMed] [Google Scholar]
  7. Kluft C., Verheijen J. H., Jie A. F., Rijken D. C., Preston F. E., Sue-Ling H. M., Jespersen J., Aasen A. O. The postoperative fibrinolytic shutdown: a rapidly reverting acute phase pattern for the fast-acting inhibitor of tissue-type plasminogen activator after trauma. Scand J Clin Lab Invest. 1985 Nov;45(7):605–610. doi: 10.3109/00365518509155267. [DOI] [PubMed] [Google Scholar]
  8. Kruithof E. K., Tran-Thang C., Ransijn A., Bachmann F. Demonstration of a fast-acting inhibitor of plasminogen activators in human plasma. Blood. 1984 Oct;64(4):907–913. [PubMed] [Google Scholar]
  9. Lacave R., Rondeau E., Ochi S., Delarue F., Schleuning W. D., Sraer J. D. Characterization of a plasminogen activator and its inhibitor in human mesangial cells. Kidney Int. 1989 Mar;35(3):806–811. doi: 10.1038/ki.1989.56. [DOI] [PubMed] [Google Scholar]
  10. Laug W. E. Vascular smooth muscle cells inhibit the plasminogen activators secreted by endothelial cells. Thromb Haemost. 1985 Apr 22;53(2):165–169. [PubMed] [Google Scholar]
  11. Laurell C. B. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem. 1966 Apr;15(1):45–52. doi: 10.1016/0003-2697(66)90246-6. [DOI] [PubMed] [Google Scholar]
  12. Loskutoff D. J., van Mourik J. A., Erickson L. A., Lawrence D. Detection of an unusually stable fibrinolytic inhibitor produced by bovine endothelial cells. Proc Natl Acad Sci U S A. 1983 May;80(10):2956–2960. doi: 10.1073/pnas.80.10.2956. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. MacGregor I. R., Booth N. A. An enzyme-linked immunosorbent assay (ELISA) used to study the cellular secretion of endothelial plasminogen activator inhibitor (PAI-1). Thromb Haemost. 1988 Feb 25;59(1):68–72. [PubMed] [Google Scholar]
  14. Scheinman J. I., Fish A. J., Brown D. M., Michael A. J. Human glomerular smooth muscle (mesangial) cells in culture. Lab Invest. 1976 Feb;34(2):150–158. [PubMed] [Google Scholar]
  15. Simpson A. J., Booth N. A., Moore N. R., Bennett B. The platelet and plasma pools of plasminogen activator inhibitor (PAI-1) vary independently in disease. Br J Haematol. 1990 Aug;75(4):543–548. doi: 10.1111/j.1365-2141.1990.tb07796.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES